{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T18:11:02Z","timestamp":1792260662667,"version":"4.4.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.vaccine.2017.11.062","type":"journal-article","created":{"date-parts":[[2017,11,26]],"date-time":"2017-11-26T21:15:54Z","timestamp":1511730954000},"page":"1-3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Measles and rubella eradication"],"prefix":"10.1016","volume":"36","author":[{"given":"Alan R.","family":"Hinman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.11.062_b0005","unstructured":"WHO Measles Fact Page. Available at <http:\/\/www.who.int\/mediacentre\/factsheets\/fs286\/en\/> [accessed Sep 28, 2017]."},{"key":"10.1016\/j.vaccine.2017.11.062_b0010","series-title":"The eradication of infectious diseases. Dahlem Workshop Report","first-page":"47","article-title":"How is eradication to be defined and what are the biological criteria?","author":"Ottesen","year":"1998"},{"key":"10.1016\/j.vaccine.2017.11.062_b0015","series-title":"Disease eradication in the 21st century. Implications for global health. Strungmann forum reports","first-page":"1","article-title":"The eradication of infectious diseases: Understanding the lessons and advancing experience","author":"Cochi","year":"2011"},{"key":"10.1016\/j.vaccine.2017.11.062_b0020","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/clinids\/4.5.933","article-title":"World eradication of measles","volume":"4","author":"Hinman","year":"1982","journal-title":"Rev Inf Dis"},{"key":"10.1016\/j.vaccine.2017.11.062_b0025","doi-asserted-by":"crossref","unstructured":"Hopkins DR, Koplan JP, Hinman AR, Lane JM. The case for global measles eradication. Lancet 1982;1396\u20138 [June 19].","DOI":"10.1016\/S0140-6736(82)92510-7"},{"key":"10.1016\/j.vaccine.2017.11.062_b0030","doi-asserted-by":"crossref","unstructured":"Henderson DA. Global measles eradication (letter). Lancet 1982;208 [July 24].","DOI":"10.1016\/S0140-6736(82)91046-7"},{"key":"10.1016\/j.vaccine.2017.11.062_b0035","first-page":"402","article-title":"The global elimination of measles","author":"Foege","year":"1982","journal-title":"Public Health Rep"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2017.11.062_b0040","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/infdis\/jir111","article-title":"A world without measles","volume":"204","author":"Strebel","year":"2011","journal-title":"J Inf Dis."},{"key":"10.1016\/j.vaccine.2017.11.062_b0045","first-page":"61","article-title":"Meeting of the international task force for disease eradication, November 2015","volume":"91","author":"World Health Organization","year":"2016","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2017.11.062_b0050","unstructured":"Gonzalez CL. Mass campaigns and general health services. Public health papers, no. 29. Geneva: WHO; 1965."},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2017.11.062_b0055","first-page":"1","article-title":"Global disease elimination and eradication as public health strategies","volume":"48","author":"Centers for Disease Control and Prevention","year":"1999","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2017.11.062_b0060","unstructured":"Orenstein WA. Personal communication, September 7, 2017."},{"key":"10.1016\/j.vaccine.2017.11.062_b0065","series-title":"Disease eradication in the 21st century. Implications for global health. Strungmann forum reports","first-page":"203","article-title":"Integration of eradication initiatives and health systems","author":"Hinman","year":"2011"},{"key":"10.1016\/j.vaccine.2017.11.062_b0070","unstructured":"7 Assessment Report on the Global Vaccine Action Plan. Available at <http:\/\/www.who.int\/immunization\/web_7_sage_gvap_assessment_report_en.pdf?ua=1> [accessed November 14, 2017]."},{"key":"10.1016\/j.vaccine.2017.11.062_b0075","unstructured":"World Health Organization. Measles and rubella global strategic plan 2012\u20132020 midterm review. Available at <http:\/\/www.who.int\/immunization\/sage\/meetings\/2016\/october\/1_MTR_Report_Final_Color_Sept_20_v2.pdf> [accessed September 28, 2017]."},{"key":"10.1016\/j.vaccine.2017.11.062_b0080","unstructured":"Global Polio Eradication Initiative. Transition planning. Available at <http:\/\/polioeradication.org\/polio-today\/preparing-for-a-polio-free-world\/transition-planning\/> [accessed September 28, 2017]."},{"issue":"S1","key":"10.1016\/j.vaccine.2017.11.062_b0085","doi-asserted-by":"crossref","first-page":"S244","DOI":"10.1093\/infdis\/jiw567","article-title":"Contribution of global polio eradication initiative-funded personnel to the strengthening of routine immunization programs in the 10 focus countries of the polio eradication and endgame strategic plan","volume":"216","author":"Van den Ent","year":"2017","journal-title":"J Inf Dis"},{"key":"10.1016\/j.vaccine.2017.11.062_b0090","unstructured":"Gavi, the Vaccine Alliance. Transition process. Available at <http:\/\/www.gavi.org\/support\/sustainability\/transition-process\/> [accessed September 28, 2017]."},{"key":"10.1016\/j.vaccine.2017.11.062_b0095","unstructured":"WHO, Unpublished data."},{"key":"10.1016\/j.vaccine.2017.11.062_b0100","unstructured":"World Health Organization. Immunization coverage. Available at <http:\/\/www.who.int\/mediacentre\/factsheets\/fs378\/en\/> [accessed September 28, 2017]."},{"key":"10.1016\/j.vaccine.2017.11.062_b0105","unstructured":"Gavi, the Vaccine Alliance. Measles and measles-rubella vaccine support. Available at <http:\/\/www.gavi.org\/support\/nvs\/measles-rubella\/> [accessed September 28, 2017]."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17316468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17316468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:24:36Z","timestamp":1759400676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17316468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0264410X17316468"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.11.062","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Measles and rubella eradication","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.11.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}